Propofol 10 mg/ml Emulsion for injection/infusion.
*Company:
Baxter Holding B.V.Status:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 26 September 2024
File name
uk-ie-mockup-var047-propofol-10mg.pdf
Reasons for updating
- Change to section 4 - possible side effects
- Change to date of revision
Updated on 26 September 2024
File name
ie_spc_Propofol 10mg_PA2299-038-001_September 2024.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 24 July 2023
File name
uk-ie-pl-2022-11-propo-10-clean PIL.pdf
Reasons for updating
- New PIL for new product
Updated on 24 July 2023
File name
propofol10-spc-2023-07-c.pdf
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 6.3 - Shelf life
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 07 November 2022
File name
ie-spc-2021-04-08-propo-mct10-var30-national-c.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Baxter Holding B.V.
Address:
Kobaltweg 49, 3542CE Utrecht, NetherlandsMedical Information E-mail:
medinfo_uki@baxter.comTelephone:
+44 (0)1635 206 345Medical Information Facsimile:
+44 (0)1635 206071Medical Information Direct Line:
+44 (0)1635 206345